David Gitlin

10.2k total citations · 3 hit papers
175 papers, 7.1k citations indexed

About

David Gitlin is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, David Gitlin has authored 175 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 29 papers in Hematology and 23 papers in Molecular Biology. Recurrent topics in David Gitlin's work include Immunodeficiency and Autoimmune Disorders (29 papers), Blood groups and transfusion (23 papers) and Blood disorders and treatments (10 papers). David Gitlin is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (29 papers), Blood groups and transfusion (23 papers) and Blood disorders and treatments (10 papers). David Gitlin collaborates with scholars based in United States, Iran and Mexico. David Gitlin's co-authors include Charles A. Janeway, Mary Boesman, Anita Perricelli, I. Herbert Scheinberg, Fred S. Rosen, John M. Craig, J Kumate, Carlos R. Morales, J. Urrusti and John M. Craig and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David Gitlin

167 papers receiving 5.9k citations

Hit Papers

Synthesis of -fetoprotein by liver, yolk sac, and gastroi... 1952 2026 1976 2001 1972 1966 1952 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Gitlin United States 45 1.5k 1.2k 1.2k 932 886 175 7.1k
Leif Wide Sweden 57 980 0.7× 942 0.8× 1.9k 1.6× 860 0.9× 730 0.8× 380 13.5k
Robert L. Baehner United States 49 3.3k 2.2× 771 0.6× 2.3k 1.9× 1.1k 1.2× 801 0.9× 186 9.2k
Frank A. Oski United States 51 419 0.3× 936 0.8× 1.1k 0.9× 2.4k 2.6× 2.1k 2.4× 254 8.7k
Markku Seppälä Finland 64 4.3k 2.9× 1.3k 1.1× 3.1k 2.6× 499 0.5× 2.1k 2.4× 372 14.3k
Michael Gregor Germany 50 784 0.5× 1.6k 1.3× 2.7k 2.2× 870 0.9× 248 0.3× 200 7.7k
Fumitake Gejyo Japan 59 2.1k 1.4× 1.7k 1.4× 4.0k 3.3× 788 0.8× 316 0.4× 461 13.1k
T. Chard United Kingdom 43 733 0.5× 909 0.7× 939 0.8× 290 0.3× 2.8k 3.1× 298 7.5k
Irving Kushner United States 56 3.3k 2.2× 2.4k 2.0× 3.4k 2.8× 1.2k 1.3× 382 0.4× 144 16.1k
Armond S. Goldman United States 47 1.6k 1.1× 659 0.5× 1.0k 0.8× 193 0.2× 557 0.6× 214 7.6k
William T. Shearer United States 46 3.2k 2.2× 439 0.4× 1.5k 1.3× 766 0.8× 680 0.8× 321 13.2k

Countries citing papers authored by David Gitlin

Since Specialization
Citations

This map shows the geographic impact of David Gitlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gitlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gitlin more than expected).

Fields of papers citing papers by David Gitlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gitlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gitlin. The network helps show where David Gitlin may publish in the future.

Co-authorship network of co-authors of David Gitlin

This figure shows the co-authorship network connecting the top 25 collaborators of David Gitlin. A scholar is included among the top collaborators of David Gitlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gitlin. David Gitlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eipper-Mains, Jodi, et al.. (2019). Life-Threatening Mistrust: Assessing and Enhancing Capacity to Trust. Psychosomatics. 60(6). 606–611. 2 indexed citations
2.
Thom, Robyn P., Shelley Hurwitz, Nomi C. Levy‐Carrick, et al.. (2018). Hospital Length of Stay With a Proactive Psychiatric Consultation Model in the Medical Intensive Care Unit: A Prospective Cohort Analysis. Psychosomatics. 60(3). 263–270. 14 indexed citations
3.
Boland, Robert, James R. Rundell, Steven Epstein, & David Gitlin. (2017). Consultation-Liaison Psychiatry vs Psychosomatic Medicine: What’s in a name?. Psychosomatics. 59(3). 207–210. 8 indexed citations
4.
Mullen, Brian, et al.. (2017). Clinical Severity Alone Does Not Determine Disposition Decisions for Patients in the Emergency Department with Suicide Risk. Psychosomatics. 59(4). 388–393. 11 indexed citations
5.
Schaffer, Adam C., et al.. (2015). A Population-Based Care Improvement Initiative for Patients at Risk for Delirium, Alcohol Withdrawal, and Suicide Harm. The Joint Commission Journal on Quality and Patient Safety. 41(7). 291–AP3. 3 indexed citations
6.
Heinrich, Thomas, Ann C. Schwartz, Paula C. Zimbrean, et al.. (2014). Recommendations for Training Psychiatry Residents in Psychosomatic Medicine. Psychosomatics. 55(5). 438–449. 12 indexed citations
7.
Weiss, Anthony P., Grace Chang, Scott L. Rauch, et al.. (2012). Patient- and Practice-Related Determinants of Emergency Department Length of Stay for Patients With Psychiatric Illness. Annals of Emergency Medicine. 60(2). 162–171.e5. 106 indexed citations
8.
Chang, Grace, Anthony P. Weiss, E. John Orav, et al.. (2011). Hospital Variability in Emergency Department Length of Stay for Adult Patients Receiving Psychiatric Consultation: A Prospective Study. Annals of Emergency Medicine. 58(2). 127–136.e1. 47 indexed citations
9.
Domek, Gretchen J., et al.. (2009). Fluoroquinolone-induced suicidal ideation. General Hospital Psychiatry. 32(1). 108–110. 17 indexed citations
10.
Gitlin, David, et al.. (2007). Foreign-Body Ingestion in Patients With Personality Disorders. Psychosomatics. 48(2). 162–166. 55 indexed citations
11.
Fireman, Philip, Horton A. Johnson, & David Gitlin. (1966). Presence of plasma cells and gamma-1-M-globulin synthesis in a patient with thymic alymphoplasia.. PubMed. 37(3). 485–92. 48 indexed citations
12.
Fireman, Philip, Mary Boesman, & David Gitlin. (1964). ATAXIA TELANGIECTASIA A DYSGAMMAGLOBULINÆMIA WITH DEFICIENT γ1A (β2A)-GLOBULIN. The Lancet. 283(7344). 1193–1195. 78 indexed citations
13.
Rosen, Fred S., David Gitlin, & Charles A. Janeway. (1962). ALYMPHOCYTOSIS, AGAMMAGLOBULINÆMIA, HOMOGRAFTS, AND DELAYED HYPERSENSITIVITY: STUDY OF A CASE. The Lancet. 280(7252). 380–381. 57 indexed citations
14.
Cruchaud, André, Fred S. Rosen, John M. Craig, Charles A. Janeway, & David Gitlin. (1962). THE SITE OF SYNTHESIS OF THE 19S γ-GLOBULINS IN DYSGAMMAGLOBULINEMIA. The Journal of Experimental Medicine. 115(6). 1141–1148. 31 indexed citations
15.
Gitlin, David, F Mönckeberg, & Charles A. Janeway. (1961). Effects of Pneumococcus Capsular Polysaccharides on the Degradation of Rabbit Antibodies in Mice. The Journal of Immunology. 86(6). 627–634. 4 indexed citations
16.
Gitlin, David & Ezio Merler. (1961). Similarity of Peptides in Two Antigen-combining Fragments released from a Rabbit Antibody by Papain. Nature. 190(4776). 634–635. 5 indexed citations
17.
Gitlin, David. (1957). DISTRIBUTION DYNAMICS OF CIRCULATING AND EXTRAVASCULAR I131 PLASMA PROTEINS. Annals of the New York Academy of Sciences. 70(1). 122–136. 17 indexed citations
18.
Gitlin, David & John M. Craig. (1956). THE NATURE OF THE HYALINE MEMBRANE IN ASPHYXIA OF THE NEWBORN. PEDIATRICS. 17(1). 64–71. 134 indexed citations
19.
Gitlin, David, et al.. (1953). THE LOCALIZATION OF HOMOLGOUS PLASMA PROTEINS IN THE TISSUES OF YOUNG HUMAN BEINGS AS DEMONSTRATED WITH FLUORESCENT ANTIBODIES. The Journal of Experimental Medicine. 97(2). 163–176. 134 indexed citations
20.
Gitlin, David, et al.. (1951). Experimental hypersensitivity in the rabbit; disappearance rates of native and labelled heterologous proteins from the serum after intravenous injection.. PubMed. 66(4). 451–61. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026